BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19430199)

  • 1. Epigenetic analysis of childhood acute lymphoblastic leukemia.
    Dunwell TL; Hesson LB; Pavlova T; Zabarovska V; Kashuba V; Catchpoole D; Chiaramonte R; Brini AT; Griffiths M; Maher ER; Zabarovsky E; Latif F
    Epigenetics; 2009 Apr; 4(3):185-93. PubMed ID: 19430199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
    Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
    Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
    Taylor KH; Pena-Hernandez KE; Davis JW; Arthur GL; Duff DJ; Shi H; Rahmatpanah FB; Sjahputera O; Caldwell CW
    Cancer Res; 2007 Mar; 67(6):2617-25. PubMed ID: 17363581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.
    Figueroa ME; Chen SC; Andersson AK; Phillips LA; Li Y; Sotzen J; Kundu M; Downing JR; Melnick A; Mullighan CG
    J Clin Invest; 2013 Jul; 123(7):3099-111. PubMed ID: 23921123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
    Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
    Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.
    Morris MR; Ricketts C; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Latif F; Maher ER
    Oncogene; 2010 Apr; 29(14):2104-17. PubMed ID: 20154727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
    Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
    Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.
    Hesson LB; Dunwell TL; Cooper WN; Catchpoole D; Brini AT; Chiaramonte R; Griffiths M; Chalmers AD; Maher ER; Latif F
    Mol Cancer; 2009 Jul; 8():42. PubMed ID: 19570220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia.
    Almamun M; Levinson BT; van Swaay AC; Johnson NT; McKay SD; Arthur GL; Davis JW; Taylor KH
    Epigenetics; 2015; 10(9):882-90. PubMed ID: 26308964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
    Tong WG; Wierda WG; Lin E; Kuang SQ; Bekele BN; Estrov Z; Wei Y; Yang H; Keating MJ; Garcia-Manero G
    Epigenetics; 2010 Aug; 5(6):499-508. PubMed ID: 20484983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
    Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
    Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.
    Kuang SQ; Tong WG; Yang H; Lin W; Lee MK; Fang ZH; Wei Y; Jelinek J; Issa JP; Garcia-Manero G
    Leukemia; 2008 Aug; 22(8):1529-38. PubMed ID: 18528427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
    Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
    Xiao J; Lee ST; Xiao Y; Ma X; Houseman EA; Hsu LI; Roy R; Wrensch M; de Smith AJ; Chokkalingam A; Buffler P; Wiencke JK; Wiemels JL
    Int J Cancer; 2014 Sep; 135(5):1101-9. PubMed ID: 24496747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.